A recent case-control study [45] included 779 jewish women affected by hereditary ovarian cancer who had undergone genetic testing for three Askhenazi founder mutations (BRCA1 185delAG, 5382insC; BRCA2 617delT). Here, BRCA2 is linked to ovarian carcinoma.